Key result
Clinician override of low-risk HEART scores linked to ~5-fold higher 30-day MACE.
Why the study?
To evaluate whether hospital admission of emergency department patients despite low-risk HEART scores (<4) identifies a subgroup at higher risk for 30-day MACE and whether clinician override provides prognostic information beyond the score.
Does clinician override (hospital admission) identify a higher risk of 30-day MACE in emergency department patients with chest pain and low-risk HEART scores compared to discharge?
Cohort (n=33,392)
Yes
Does clinician override (hospital admission) identify a higher risk of 30-day MACE in emergency department patients with chest pain and low-risk HEART scores compared to discharge?
Clinician override of low-risk HEART scores in the emergency department identifies a subgroup of patients at substantially higher risk for 30-day major adverse cardiovascular events, providing incremental prognostic value beyond structured risk scores.
Answers are grounded in this paper and cite their sources.
Override flags higher MACE risk beyond HEART score; hypothesis-generating and should not yet change discharge practice.
Objective To evaluate whether hospital admission of emergency department (ED) patients despite low-risk History, Electrocardiogram, Age, Risk factors, and Troponin (HEART) scores (<4) identifies a subgroup at higher risk for 30-day major adverse cardiovascular events (MACE) and to determine whether clinician override provides prognostic information beyond the HEART score. Methods We conducted a retrospective, multicenter observational study across 6 EDs from January 1, 2021, through December 31, 2023. Adult patients presenting with chest pain and a documented HEART score were included. Analyses were restricted to first encounters among patients with low-risk HEART scores (<4). Clinician override was defined as hospital admission despite low-risk classification. The primary outcome was 30-day MACE, defined as myocardial infarction (MI), coronary revascularization, or all-cause mortality. Multivariable logistic regression identified factors associated with clinician override and evaluated the independent association between clinician override and 30-day MACE after adjustment for age, sex, race or ethnicity, study site, HEART score variables, troponin trend, chronic heart failure, and chronic kidney disease. Incremental prognostic value was assessed using the likelihood ratio and DeLong tests. Results Among 33,392 patients with low-risk HEART scores, clinician override occurred in 2101 (6.3%). Thirty-day MACE occurred in 120 patients (0.36%), including 40 of 2101 admitted patients (1.90%) and 80 of 31,291 discharged patients (0.26%). Clinician override was independently associated with higher odds of 30-day MACE (adjusted odds ratio, 5.16; 95% CI, 3.40 to 7.82). Clinician override significantly improved prediction of 30-day MACE beyond the baseline clinical model (AUROC, 0.8006 vs. 0.8287; DeLong P = .0026; likelihood ratio χ 2 = 49.82, P <.001). Conclusion Among ED patients with low-risk HEART scores, clinician override was uncommon but identified a subgroup at substantially higher risk for 30-day MACE. Although clinician override was largely associated with measurable clinical characteristics, it provided incremental prognostic information beyond the HEART score and major comorbidities, supporting the complementary role of clinician judgment in risk stratification.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a cohort in Emergency department chest pain with low-risk HEART score (<4) (n=33,392). Clinician override (hospital admission despite low-risk HEART score) vs. Discharged from the emergency department was evaluated on 30-day major adverse cardiovascular events (MACE), defined as myocardial infarction, coronary revascularization, or all-cause mortality (adjusted OR 5.16, 95% CI 3.40 to 7.82). Among emergency department patients with low-risk HEART scores, clinician override (hospital admission) was independently associated with higher odds of 30-day MACE (adjusted OR 5.16) compared to discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: